SINGLE
ENZYME
ACTIVITY-BASED
LIQUID
BIOPSY
We revolutionize disease diagnosis and drug development with
'Single Enzyme Activity-based Liquid Biopsy' technology.
News
-
Award
Cosomil Secures Grant from NEDO’s Deep Tech Support Program STS Phase
-
Other
Our Laboratory Achieves Clinical Laboratory Registration
-
Research
Research Achievements Towards Company Founding Published in Cell Reports Methods
-
Research
Cosomil and Takeda Commence Collaboration on Enzyme Activity Biomarker Measurement
Science
We are advancing high-precision liquid-based diagnostics
using 'Single Enzyme Activity-based Protein Profiling (SEAP),'
enabling enzyme activity analysis at single protein level.
![1分子計測リキッドバイオプシー](https://cosomil.com/wp-content/themes/cosomil/images/common/item_01.png)
Services
Our business tagets early disease detection and drug development support.
Through SEAP technology, we have the potential to detect early-stage pancreatic cancer.
![1分子計測リキッドバイオプシー](https://cosomil.com/wp-content/themes/cosomil/images/common/item_02.png)
About
We will contribute to future growth of healthcare
by applying fluorescent enzyme substrates and microdevices.